ImmunoGenesis, a clinical-stage biotechnology company developing science-driven immune therapies, announced the appointment of seasoned industry veteran Charles Schweizer, PhD, as Senior Vice President of...
Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("A.I.") platform to transform the cost, pace, and timeline...
